Alnylam Pharmaceuticals Reports First Quarter 2006 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 9, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, today reported its consolidated financial results for the quarter ended March 31, 2006 and company highlights.